NFKB1 and invasive breast carcinoma: Additionally, miR-30c-2-3p has been shown to act as a negative regulator of NF-κB signaling, and ectopic expression of miR-30c-2-3p attenuates cell proliferation by targeting TRADD and CCNE1 in BrCa cells [38].